Daly, J M <br/><br/>
NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.  [electronic resource] 

 -  Oncogene  Jun 1999 
 - 3440-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1202700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>CSK Tyrosine-Protein Kinase<br/>Calcium-Calmodulin-Dependent Protein Kinases--physiology<br/>Cell Cycle--drug effects<br/>Cell Division--drug effects<br/>Enzyme Activation<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--metabolism<br/>G1 Phase--drug effects<br/>G2 Phase--drug effects<br/>Glycoproteins--pharmacology<br/>Humans<br/>Mitogen-Activated Protein Kinases<br/>Neuregulins<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Protein-Tyrosine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Receptor, ErbB-2--metabolism<br/>Receptor, ErbB-3<br/>Signal Transduction<br/>Tumor Cells, Cultured<br/>p38 Mitogen-Activated Protein Kinases<br/>src-Family Kinases